Insulin aspart, recombinant Subcutaneous and Magnesium sulfate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Magnesium sulfate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: magnesium sulfate
Brand name: Epsom Salt
Synonyms: Magnesium Sulfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Magnesium Sulfate Granules (Epsom Salt)
- Insulin aspart, recombinant Subcutaneous-Magnesium Sulfate in Dextrose Injection
- Insulin aspart, recombinant Subcutaneous-Magnesium sulfate injection
- Insulin aspart, recombinant Subcutaneous-Magnesium sulfate Oral, Topical application, Route Not Applicable
- Insulin aspart, recombinant Subcutaneous-Magnesium sulfate, potassium sulfate, and sodium sulfate
- Insulin aspart, recombinant Subcutaneous-Magnesium Sulfate-Sodium Chloride injection
- Magnesium sulfate-Insulin degludec
- Magnesium sulfate-Insulin Degludec (U-100) Prefilled Pens
- Magnesium sulfate-Insulin Degludec (U-100) Vials
- Magnesium sulfate-Insulin Degludec (U-200) Prefilled Pens
- Magnesium sulfate-Insulin degludec and liraglutide
- Magnesium sulfate-Insulin degludec and liraglutide Subcutaneous